GSK Investigational Site

Santo Tomé, Santa Fe Province 3016

0 studies enrolling now · 1 studies all time

What they study most

Pulmonary Disease, Chronic Obstructive

Studies at this site

• Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) — Stopped early